Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45,731 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Phase I, Randomized, Double-Blind, Single-Dose, Parallel-Group Study to compare Pharmacokinetic Similarity, Safety, and Immunogenicity Between BAT2506 and Golimumab in Healthy Chinese Male Subjects.
Wu M, Sun J, Wu D, Xu J, Wei J, Wang Z, Yu J, Li S, Zhang H, Ding Y. Wu M, et al. Among authors: sun j. Expert Opin Investig Drugs. 2021 Jan;30(1):77-83. doi: 10.1080/13543784.2021.1851364. Epub 2020 Nov 26. Expert Opin Investig Drugs. 2021. PMID: 33241960 Clinical Trial.
Pharmacokinetics, safety, and immunogenicity of HLX03, an adalimumab biosimilar, compared with reference biologic in healthy Chinese male volunteers: Results of a randomized, double-blind, parallel-controlled, phase 1 study.
Zhang H, Wu M, Sun J, Zhu X, Li C, Ding Y, Zhang X, Chai K, Li X. Zhang H, et al. Among authors: sun j. Pharmacol Res Perspect. 2021 Apr;9(2):e00733. doi: 10.1002/prp2.733. Pharmacol Res Perspect. 2021. PMID: 33682358 Free PMC article. Clinical Trial.
A phase 1 randomized study compare the pharmacokinetics, safety and immunogenicity of HLX04 to reference bevacizumab sourced from the United States, the European Union, and China in healthy Chinese male volunteers.
Zhu X, Qian H, Sun J, Wu M, Yu C, Ding Y, Zhang X, Chai K, Li X. Zhu X, et al. Among authors: sun j. Cancer Chemother Pharmacol. 2021 Sep;88(3):465-474. doi: 10.1007/s00280-021-04297-z. Epub 2021 Jun 4. Cancer Chemother Pharmacol. 2021. PMID: 34086067 Free PMC article. Clinical Trial.
Comparison of pharmacokinetics and safety between CE-fosphenytoin sodium, fosphenytoin sodium, and phenytoin sodium after intravenous and intramuscular administration in healthy volunteers.
Li X, Wu M, Sun J, Jin W, Han L, Xu J, Liu J, Zhang H, Wang J, Wang D, Zhang H, Zhang Q, Liu N, Ding Y. Li X, et al. Among authors: sun j. Front Pharmacol. 2023 Nov 17;14:1204075. doi: 10.3389/fphar.2023.1204075. eCollection 2023. Front Pharmacol. 2023. PMID: 38044946 Free PMC article.
[Efficacy and safety of dienogest on ovarian endometrioma].
Sun JF, Wang XL, Yu WN, Pan SY, Ding Y, Dai HH, Wang XL. Sun JF, et al. Zhonghua Fu Chan Ke Za Zhi. 2024 Sep 25;59(9):692-701. doi: 10.3760/cma.j.cn112141-20240516-00282. Zhonghua Fu Chan Ke Za Zhi. 2024. PMID: 39313421 Chinese.
45,731 results
You have reached the last available page of results. Please see the User Guide for more information.